Chronic Bronchitis: Clinical Trials

11 trials for Chronic Bronchitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Completed 11
Phase 12Completed 2
Phase 31Completed 1

Follow Chronic Bronchitis: new trials by email Literature Review of Chronic Bronchitis trials Research Report on Chronic Bronchitis

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes
E-Cigarette, Financial Incentives - Chronic Obstructive Pulmonary Disease, Chronic Bronchitis
Phase 2CompletedUniversity of Vermont212022-04-282024-02-08
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis
Tozorakimab, Placebo - Chronic Obstructive Pulmonary Disease (COPD), Chronic Bronchitis
Phase 2CompletedAstraZeneca1372020-12-142025-02-27
The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor
Ivacaftor 150 MG, Placebo - Chronic Obstructive Pulmonary Disease, Chronic Bronchitis
Phase 2CompletedUniversity of Alabama at Birmingham402017-03-162024-12-12
Postoperative Rehabilitation After Cardiac Surgery in Patients at Risk of Respiratory Complications. Effects of a Continuous Bi-laterosternal Infusion of Ropivacaine Through Multihole Catheters
Ropivacaine, placebo - Scheduled Cardiac Surgery, Sternotomy
Phase 2CompletedUniversity Hospital, Clermont-Ferrand1202013-04-272026-08-06
Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis
YHD001 dose level 1, YHD001 dose level 2, Pelargonium sidoides extract - Acute Bronchitis, Chronic Bronchitis
Phase 2CompletedYuhan Corporation1182011-09-012013-09-26
PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Prochymal™, Placebo - Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema
Phase 2CompletedMesoblast, Inc.622008-03-202026-03-11
Helium:Oxygen Noninvasive Positive Pressure Ventilation in Patients Exposed to Sulfur Mustard
helium:oxygen mixture - Bronchiolitis, Chronic Bronchitis
Phase 2 / Phase 3CompletedBaqiyatallah Medical Sciences University232007-04-012008-03-25
Real-Time Support for Exercise Persistence in COPD
Coached exercise persistence intervention, Self-Monitored exercise persistence intervention - Pulmonary Disease, Chronic Obstructive, COPD
Phase 1 / Phase 2CompletedUniversity of Washington172006-05-012009-12-07
Phase 2 Study - Erdosteine in Patients With CB/COPD
Erdosteine - Chronic Bronchitis, Chronic Obstructive Pulmonary Disease
Phase 2CompletedAdams Respiratory Therapeutics4002006-03-012007-12-06
Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD)
yoga - Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive
Phase 1 / Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)362003-01-012006-08-18
Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis
Oral N-acetycystein (NAC) - Chronic Bronchitis
Phase 2CompletedWake Forest University2401997-01-012017-11-06

Narrower conditions

Bronchitis, Chronic (11)  ·  Pulmonary Disease, Chronic Obstructive (7)  ·  Emphysema (2)  ·  Pulmonary Emphysema (2)  ·  Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (1)  ·  Bronchiolitis (1)  ·  Bronchitis (1)  ·  Inflammation (1)  ·  Lung Diseases, Obstructive (1)  ·  Motor Activity (1)  ·  Obesity (1)  ·  Pain, Postoperative (1)  ·  Vaping (1)

Broader conditions

Bronchial Diseases (11)  ·  Chronic Disease (11)  ·  Disease Attributes (11)  ·  Infections (11)  ·  Lung Diseases (11)  ·  Pathologic Processes (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Respiratory Tract Diseases (11)  ·  Respiratory Tract Infections (11)  ·  Bronchitis (10)  ·  Lung Diseases, Obstructive (10)  ·  Pulmonary Disease, Chronic Obstructive (4)  ·  Behavior (2)  ·  Asthma (1)  ·  Body Weight (1)

Interventions

Electronic Nicotine Delivery Systems (1)  ·  Ropivacaine (1)  ·  Yoga (1)  ·  erdosteine (1)  ·  ivacaftor (1)  ·  remestemcel-l (1)

Sponsors

Adams Respiratory Therapeutics (1)  ·  AstraZeneca (1)  ·  Baqiyatallah Medical Sciences University (1)  ·  Mesoblast, Inc. (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University of Alabama at Birmingham (1)  ·  University of Vermont (1)  ·  University of Washington (1)  ·  Wake Forest University (1)  ·  Yuhan Corporation (1)

Countries

United States (8)  ·  Australia (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Iran (1)  ·  Israel (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Poland (1)  ·  South Africa (1)  ·  South Korea (1)

Top investigators

Bruce K Rubin, MEng,MD,MBA (1)  ·  Christopher James, PA (1)  ·  Diann E Gaalema, PhD (1)  ·  Helmut Albrecht, MD (1)  ·  Huong Q. Nguyen, PhD (1)  ·  Vedat Eljezi (1)  ·  Virginia Carrieri-Kohlman, RN, DNSc (1)  ·  Young Kyoon Kim, M.D., Ph.D. (1)

Results publications

PMID 19750190, PMID 22292600, PMID 22772084, PMID 23172272, PMID 27977439, PMID 33964910, PMID 39316773

NIH funding

R03NR009361 (1), R34HL127166 (1), U54DA036114 (1)